Here are the top stocks on the brokerages radar-:
CLSA on Aurobindo Pharma
- Cuts rating from BUY to Outperform on limited upside
- Sets price target at Rs 1040/share (+4% upside)
- Limited upside following the recent rally leading to cut in rating
Morgan Stanley on Glenmark Pharma
- Raises price target to Rs 554/sh vs Rs 424/share earlier
- Expect 8-10 launches (including three niche products) in the US
- Retain Underweight rating on the stock
ICICI Sec on PNB Housing Finance
- Upgrade to BUY rating
- Raise price target to Rs 678/sh vs Rs 385/sh earlier
- Board approval for preferential issue to Carlyle reduces overhang
- Aditya Puri’s nomination to the Board will lend considerable credence
Kotak Instl Equities on Karur Vysya Bank
- Maintain Buy rating, Price target at Rs 65/sh
- Decline in operating profits on account of lower provisions
- Asset quality is showing resilience